Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1376)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,240
Price
$539.82
Total Value
$669.37K
Shares Held After
1,650
% of Holdings
42.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
720
Price
$538.94
Total Value
$388.04K
Shares Held After
2,890
% of Holdings
19.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,077
Price
$537.90
Total Value
$579.31K
Shares Held After
3,610
% of Holdings
23.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,772
Price
$536.83
Total Value
$951.27K
Shares Held After
4,687
% of Holdings
27.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,955
Price
$536.02
Total Value
$1.05M
Shares Held After
6,459
% of Holdings
23.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
60
Price
$532.97
Total Value
$31.98K
Shares Held After
8,930
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$532.16
Total Value
$340.58K
Shares Held After
8,990
% of Holdings
6.6%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
5,400
Price
$13.43
Total Value
$72.52K
Shares Held After
512,272
% of Holdings
1.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
13,660
Price
$12.63
Total Value
$172.53K
Shares Held After
517,672
% of Holdings
2.6%
Sarepta Therapeutics, Inc. (SRPT)
Mayo Stephen — Director
Shares
7,239
Price
$17.02
Total Value
$123.21K
Shares Held After
1,765
% of Holdings
80.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
300
Price
$85.53
Total Value
$25.66K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
200
Price
$83.38
Total Value
$16.68K
Shares Held After
300
% of Holdings
40.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
3,865
Price
$82.66
Total Value
$319.48K
Shares Held After
500
% of Holdings
88.5%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
900
Price
$85.53
Total Value
$76.98K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
23,465
Price
$81.75
Total Value
$1.92M
Shares Held After
4,365
% of Holdings
84.3%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
200
Price
$83.38
Total Value
$16.68K
Shares Held After
900
% of Holdings
18.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
15,852
Price
$80.71
Total Value
$1.28M
Shares Held After
27,830
% of Holdings
36.3%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
12,796
Price
$82.60
Total Value
$1.06M
Shares Held After
1,100
% of Holdings
92.1%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
65,517
Price
$81.74
Total Value
$5.36M
Shares Held After
13,896
% of Holdings
82.5%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
43,505
Price
$80.69
Total Value
$3.51M
Shares Held After
79,413
% of Holdings
35.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
33,830
Price
$81.48
Total Value
$2.76M
Shares Held After
0
% of Holdings
100.0%
Crinetics Pharmaceuticals, Inc. (CRNX)
Vivaldi Coelho Rogerio — Director
Shares
523
Price
$36.77
Total Value
$19.23K
Shares Held After
16,300
% of Holdings
3.1%
Crinetics Pharmaceuticals, Inc. (CRNX)
Vivaldi Coelho Rogerio — Director
Shares
4,477
Price
$36.08
Total Value
$161.53K
Shares Held After
16,823
% of Holdings
21.0%
PTC THERAPEUTICS, INC. (PTCT)
Klein Matthew B. — Director
Shares
2,662
Price
$64.08
Total Value
$170.58K
Shares Held After
396,920
% of Holdings
0.7%
BiomX Inc. (PHGE)
Yeganeh Reuven — Director
Shares
300,000
Price
$5.00
Total Value
$1.50M
Shares Held After
0
% of Holdings
100.0%
ONCOLYTICS BIOTECH INC (ONCY)
Kelly Jared — Director
Shares
5,050
Price
$0.96
Total Value
$4.85K
Shares Held After
114,050
% of Holdings
4.4%
Lineage Cell Therapeutics, Inc. (LCTX)
Culley Brian M — Director
Shares
15,000
Price
$1.62
Total Value
$24.38K
Shares Held After
255,516
% of Holdings
5.9%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.08
Total Value
$268.36K
Shares Held After
516,610
% of Holdings
3.6%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
122,523
Price
$13.17
Total Value
$1.61M
Shares Held After
520,948
% of Holdings
19.0%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
30,593
Price
$14.08
Total Value
$430.75K
Shares Held After
291,374
% of Holdings
9.5%
Adaptive Biotechnologies Corp (ADPT)
GRIFFIN MICHELLE RENEE — Director
Shares
15,394
Price
$13.91
Total Value
$214.13K
Shares Held After
15,625
% of Holdings
49.6%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
329,600
Price
$13.17
Total Value
$4.34M
Shares Held After
2,301,113
% of Holdings
12.5%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
140,567
Price
$13.17
Total Value
$1.85M
Shares Held After
2,630,713
% of Holdings
5.1%
Adaptive Biotechnologies Corp (ADPT)
BOBULSKY SUSAN — Chief Commercial Officer, MRD
Shares
41,338
Price
$13.17
Total Value
$544.42K
Shares Held After
427,775
% of Holdings
8.8%
Adaptive Biotechnologies Corp (ADPT)
BENZENO SHARON — Chief Commercial Ofc Imm Med
Shares
63,103
Price
$13.17
Total Value
$831.07K
Shares Held After
272,751
% of Holdings
18.8%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
329,600
Price
$13.17
Total Value
$4.34M
Shares Held After
1,522,058
% of Holdings
17.8%
Adaptive Biotechnologies Corp (ADPT)
PISKEL KYLE — Chief Financial Officer
Shares
18,672
Price
$13.17
Total Value
$245.91K
Shares Held After
259,840
% of Holdings
6.7%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
140,666
Price
$13.17
Total Value
$1.85M
Shares Held After
1,851,658
% of Holdings
7.1%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
3,418
Price
$75.86
Total Value
$259.29K
Shares Held After
1,152,987
% of Holdings
0.3%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
8,219
Price
$74.83
Total Value
$615.03K
Shares Held After
1,156,405
% of Holdings
0.7%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
8,363
Price
$74.29
Total Value
$621.29K
Shares Held After
1,164,624
% of Holdings
0.7%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
3,057
Price
$225.00
Total Value
$687.83K
Shares Held After
21,010
% of Holdings
12.7%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
341
Price
$300.00
Total Value
$102.30K
Shares Held After
0
% of Holdings
100.0%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
129,672
Price
$19.52
Total Value
$2.53M
Shares Held After
4,644,386
% of Holdings
2.7%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
2,000
Price
$19.35
Total Value
$38.70K
Shares Held After
13,500
% of Holdings
14.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
McKechnie Duncan — EVP, Chief Commercial Officer
Shares
2,633
Price
$498.42
Total Value
$1.31M
Shares Held After
12,489
% of Holdings
17.4%
ONCOLYTICS BIOTECH INC (ONCY)
Parsons James T. — Director
Shares
10,000
Price
$1.03
Total Value
$10.30K
Shares Held After
41,849
% of Holdings
23.9%
BIOMARIN PHARMACEUTICAL INC (BMRN)
Guyer Charles Greg — EVP, Chief Technical Officer
Shares
16,486
Price
$60.46
Total Value
$996.74K
Shares Held After
79,953
% of Holdings
17.1%
CRISPR Therapeutics AG (CRSP)
KASINGER JAMES R. — General Counsel and Secretary
Shares
2,800
Price
$52.80
Total Value
$147.84K
Shares Held After
87,815
% of Holdings
3.1%
CRISPR Therapeutics AG (CRSP)
Kulkarni Samarth — Director
Shares
9,798
Price
$52.80
Total Value
$517.33K
Shares Held After
235,558
% of Holdings
4.0%
Showing 401–450 of 1376 transactions (page 9 of 28)